Related Experiment Videos
Immediate and long-term results in aortic valve replacement.
Scandinavian Journal of Thoracic and Cardiovascular Surgery
|January 1, 1984
Summary
Myocardial protection method significantly impacts aortic valve replacement surgery mortality. Chemical cardioplegia reduced perioperative deaths by 18% compared to normothermia, with long-term outcomes independent of prosthesis type.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Aortic Valve Disease Management
Background:
- Isolated aortic valve disease necessitates surgical intervention.
- Valve replacement surgery has evolved over decades.
- Assessing long-term outcomes is crucial for patient management.
Purpose of the Study:
- To evaluate the long-term results of aortic valve replacement surgery.
- To determine the impact of myocardial protection strategies on perioperative mortality.
- To analyze factors influencing patient outcomes, including NYHA functional class and prosthesis type.
Main Methods:
- Retrospective analysis of 127 patients undergoing isolated aortic valve replacement.
- Comparison of outcomes between patients operated on during two distinct periods (1967-1974 and later).
- Assessment of perioperative mortality based on myocardial protection methods (normothermia vs. chemical cardioplegia).
Main Results:
- Perioperative mortality was significantly lower with chemical cardioplegia (6%) compared to normothermia (18%).
- No significant correlation was observed between preoperative NYHA functional class and mortality or complication rates.
- Long-term patient outcomes were not significantly influenced by the type of valvular prosthesis used.
Conclusions:
- The choice of myocardial protection strategy is a critical determinant of perioperative mortality in aortic valve replacement.
- Early and late outcomes of aortic valve replacement are influenced by surgical techniques and patient factors.
- Chemical cardioplegia represents a superior method for myocardial protection during aortic valve surgery, reducing mortality risk.